title: [Cross-hypersensitivity syndrome between antiepileptic drugs: report of a case].
abstract: Antiepileptic hypersensitivity syndrome (SHA) is a rare (1/1.000 to 1/10.000 in new exposures) but potentially life-threatening syndrome that occurs after exposure to an anticonvulsant, most commonly the aromatic ones such as phenytoin, carbamazepine or phenobarbital. Clinical features of this syndrome include cutaneous reactions, fever, lymphadenopaties, eosinophilia and internal organ involvement (mainly liver, but also kidney, CNS, heart or lung). We present a case report of a 61-year-old woman treated with phenobarbital who developed a cutaneous eruption attributed to this drug. Treatment was changed to phenytoin and after 17 days the patient developed cutaneous rash, eosinophilia and an increase in transaminase levels. The high rate of cross-sensitivity between aromatic anticonvulsants (40-80%) suggests a link between a hypersensitivity reaction to phenytoin and the previous reaction to phenobarbital.
authors.affiliation: Servicio de Farmacia, Hospital Miguel Servet, Zaragoza.
authors.forename: M A
authors.initials: MA
authors.lastname: Allende Bandrés
authors.forename: M
authors.initials: M
authors.lastname: Izuel Rami
authors.forename: E
authors.initials: E
authors.lastname: Urbieta Sanz
authors.forename: I
authors.initials: I
authors.lastname: Villar Fernández
authors.forename: J
authors.initials: J
authors.lastname: Carcelén Andrés
mesh_terms: D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000150:complications / Q000532:radiotherapy / Q000601:surgery; D002998:Clonazepam / Q000627:therapeutic use; D016371:Cranial Irradiation / Q000009:adverse effects; D003429:Cross Reactions; D004198:Disease Susceptibility; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D005909:Glioblastoma / Q000150:complications / Q000532:radiotherapy / Q000601:surgery; D006801:Humans; D007889:Leiomyoma / Q000601:surgery; D008875:Middle Aged; D016609:Neoplasms, Second Primary; D010296:Parietal Lobe; D010634:Phenobarbital / Q000009:adverse effects* / Q000627:therapeutic use; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use*; D018714:Radiotherapy, Adjuvant / Q000009:adverse effects; D012640:Seizures / Q000188:drug therapy / Q000209:etiology; D014594:Uterine Neoplasms / Q000601:surgery; D014635:Valproic Acid / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D002998:Clonazepam; D014635:Valproic Acid; D010672:Phenytoin; D010634:Phenobarbital